We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Tyra Biosciences Inc is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Tyra Biosciences Inc is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer.
Tyra Biosciences Announces Preclinical Proof-of-Concept Results with TYRA-300 in Hypochondroplasia (HCH) PR Newswire CARLSBAD, Calif., July 2, 2024 - In a preclinical HCH model, TYRA-300...
Tyra Biosciences to Present at Upcoming Investor Conferences PR Newswire CARLSBAD, Calif., May 23, 2024 CARLSBAD, Calif., May 23, 2024 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.11 | -0.554435483871 | 19.84 | 21.64 | 19.03 | 104429 | 20.22592317 | CS |
| 4 | 2.53 | 14.7093023256 | 17.2 | 21.64 | 15.25 | 192640 | 17.17927481 | CS |
| 12 | 3.96 | 25.1109701966 | 15.77 | 21.64 | 15.25 | 159484 | 17.75445913 | CS |
| 26 | 6.49 | 49.0181268882 | 13.24 | 21.64 | 12.34 | 147003 | 17.42207845 | CS |
| 52 | 3.46 | 21.2661339889 | 16.27 | 21.64 | 10.38 | 107095 | 16.17049591 | CS |
| 156 | -10.17 | -34.0133779264 | 29.9 | 31.36 | 4.93 | 106087 | 14.92214632 | CS |
| 260 | -10.17 | -34.0133779264 | 29.9 | 31.36 | 4.93 | 106087 | 14.92214632 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
